Gabriel S Mercado
Examiner (ID: 12823, Phone: (408)918-7537 , Office: P/3685 )
Most Active Art Unit | 3685 |
Art Unit(s) | 2171, 3685, 2175 |
Total Applications | 208 |
Issued Applications | 68 |
Pending Applications | 47 |
Abandoned Applications | 93 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18910330
[patent_doc_number] => 11873299
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-16
[patent_title] => 7-(4-((5-(4-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)iperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound
[patent_app_type] => utility
[patent_app_number] => 18/372395
[patent_app_country] => US
[patent_app_date] => 2023-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3904
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18372395
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/372395 | 7-(4-((5-(4-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)iperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound | Sep 24, 2023 | Issued |
Array
(
[id] => 18980130
[patent_doc_number] => 11905290
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-02-20
[patent_title] => 5-substituted aminopyrimido[6',1':2,3]imidazo[4,5-c][1,6]naphthyridine compounds as CK2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/242152
[patent_app_country] => US
[patent_app_date] => 2023-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8959
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18242152
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/242152 | 5-substituted aminopyrimido[6',1':2,3]imidazo[4,5-c][1,6]naphthyridine compounds as CK2 inhibitors | Sep 4, 2023 | Issued |
Array
(
[id] => 18922911
[patent_doc_number] => 20240025915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => SOLID FORMS OF 4-(3,3-DIFLUORO-2,2-DIMETHYL-PROPANOYL)-3,5-DIHYDRO-2H-PYRIDO[3,4-F][1,4]OXAZEPINE-9-CARBONITRILE
[patent_app_type] => utility
[patent_app_number] => 18/225236
[patent_app_country] => US
[patent_app_date] => 2023-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18225236
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/225236 | SOLID FORMS OF 4-(3,3-DIFLUORO-2,2-DIMETHYL-PROPANOYL)-3,5-DIHYDRO-2H-PYRIDO[3,4-F][1,4]OXAZEPINE-9-CARBONITRILE | Jul 23, 2023 | Pending |
Array
(
[id] => 18837673
[patent_doc_number] => 11845734
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-19
[patent_title] => Selective 5-LO inhibitors for the treatment of bronchial asthma
[patent_app_type] => utility
[patent_app_number] => 18/215077
[patent_app_country] => US
[patent_app_date] => 2023-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7197
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18215077
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/215077 | Selective 5-LO inhibitors for the treatment of bronchial asthma | Jun 26, 2023 | Issued |
Array
(
[id] => 19274417
[patent_doc_number] => 12024528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Bridged tricyclic carbamoylpyridone compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/334611
[patent_app_country] => US
[patent_app_date] => 2023-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75876
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18334611
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/334611 | Bridged tricyclic carbamoylpyridone compounds and uses thereof | Jun 13, 2023 | Issued |
Array
(
[id] => 18552099
[patent_doc_number] => 20230250105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
[patent_app_type] => utility
[patent_app_number] => 18/175030
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175030 | Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity | Feb 26, 2023 | Pending |
Array
(
[id] => 18418519
[patent_doc_number] => 20230172977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/102474
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 297
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102474 | THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME | Jan 26, 2023 | Pending |
Array
(
[id] => 18391347
[patent_doc_number] => 20230159565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Solid Forms of Substituted Benzoxaborole and Compositions Thereof
[patent_app_type] => utility
[patent_app_number] => 18/094502
[patent_app_country] => US
[patent_app_date] => 2023-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18094502
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/094502 | Solid forms of substituted benzoxaborole and compositions thereof | Jan 8, 2023 | Issued |
Array
(
[id] => 18559757
[patent_doc_number] => 11724991
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-08-15
[patent_title] => Selective 5-LO inhibitors for the treatment of bronchial asthma
[patent_app_type] => utility
[patent_app_number] => 18/094113
[patent_app_country] => US
[patent_app_date] => 2023-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7174
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18094113
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/094113 | Selective 5-LO inhibitors for the treatment of bronchial asthma | Jan 5, 2023 | Issued |
Array
(
[id] => 18334709
[patent_doc_number] => 20230126657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => Compositions and Methods for Identifying and Treating Dystonia Disorders
[patent_app_type] => utility
[patent_app_number] => 18/082570
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082570
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/082570 | Compositions and Methods for Identifying and Treating Dystonia Disorders | Dec 14, 2022 | Pending |
Array
(
[id] => 18725758
[patent_doc_number] => 20230339967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => SOLID FORMS OF AN S1P-RECEPTOR MODULATOR
[patent_app_type] => utility
[patent_app_number] => 17/992457
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992457
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992457 | SOLID FORMS OF AN S1P-RECEPTOR MODULATOR | Nov 21, 2022 | Pending |
Array
(
[id] => 18282879
[patent_doc_number] => 20230098351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => RESPONSIVE ELASTIC POLYMERS AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/982454
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982454 | RESPONSIVE ELASTIC POLYMERS AND METHODS OF MAKING AND USING SAME | Nov 6, 2022 | Pending |
Array
(
[id] => 18360833
[patent_doc_number] => 20230142424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/978818
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17978818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/978818 | A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF USE THEREOF | Oct 31, 2022 | Pending |
Array
(
[id] => 18176952
[patent_doc_number] => 20230037681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => FOOD INGREDIENTS FROM STEVIA REBAUDIANA
[patent_app_type] => utility
[patent_app_number] => 17/969235
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/969235 | FOOD INGREDIENTS FROM STEVIA REBAUDIANA | Oct 18, 2022 | Pending |
Array
(
[id] => 18149627
[patent_doc_number] => 20230023484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => DEPOT ADMINISTRATION OF ILOPERIDONE
[patent_app_type] => utility
[patent_app_number] => 17/935911
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/935911 | DEPOT ADMINISTRATION OF ILOPERIDONE | Sep 26, 2022 | Pending |
Array
(
[id] => 18141720
[patent_doc_number] => 20230015563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => NUTRITIONAL COMPOSITIONS AND INFANT FORMULA FOR PROMOTING DE NOVO MYEALINATION
[patent_app_type] => utility
[patent_app_number] => 17/943652
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943652 | NUTRITIONAL COMPOSITIONS AND INFANT FORMULA FOR PROMOTING DE NOVO MYEALINATION | Sep 12, 2022 | Pending |
Array
(
[id] => 18285418
[patent_doc_number] => 20230100890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => USE OF COMBINED INHALANT CANNABINOID THERAPY IN THE TREATMENT OF MIGRAINE
[patent_app_type] => utility
[patent_app_number] => 17/930218
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930218
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930218 | USE OF COMBINED INHALANT CANNABINOID THERAPY IN THE TREATMENT OF MIGRAINE | Sep 6, 2022 | Pending |
Array
(
[id] => 18347237
[patent_doc_number] => 20230135347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => HYDROGELS WITH BIODEGRADABLE CROSSLINKING
[patent_app_type] => utility
[patent_app_number] => 17/930381
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 623
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930381 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | Sep 6, 2022 | Pending |
Array
(
[id] => 18250426
[patent_doc_number] => 20230077465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => LOW DOSE PRODUCT AND METHOD FOR TREATING DIARRHEA
[patent_app_type] => utility
[patent_app_number] => 17/884403
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/884403 | LOW DOSE PRODUCT AND METHOD FOR TREATING DIARRHEA | Aug 8, 2022 | Pending |
Array
(
[id] => 18565584
[patent_doc_number] => 20230255911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => COMPOSITIONS OF BIOACTIVE FULVATE FRACTIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/810805
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810805 | COMPOSITIONS OF BIOACTIVE FULVATE FRACTIONS AND USES THEREOF | Jul 4, 2022 | Pending |